Free Trial

Top Small Cap Stocks To Add to Your Watchlist - March 7th

Day One Biopharmaceuticals logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's screener flagged five Small Cap stocks with the highest recent dollar trading volume: Day One Biopharmaceuticals (DAWN), Red Cat (RCAT), Peraso (PRSO), Direxion Daily PLTR Bear 1X Shares (PLTD), and Vale (VALE).
  • Day One Biopharmaceuticals is a clinical-stage biotech whose lead candidate, tovorafenib, is an oral brain-penetrant pan‑RAF inhibitor currently in Phase II for pediatric relapsed/refractory low-grade glioma.
  • MarketBeat notes that small-cap stocks generally offer higher growth potential but come with greater volatility, lower liquidity, and higher risk than mid- and large-cap stocks.
  • MarketBeat previews the top five stocks to own by May 1st.

Day One Biopharmaceuticals, Red Cat, Peraso, Direxion Daily PLTR Bear 1X Shares, and Vale are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—typically roughly $300 million to $2 billion, though exact cutoffs vary by index or provider. Investors view them as offering higher growth potential but also greater volatility, lower liquidity, and generally higher risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma.

Read Our Latest Research Report on DAWN

Red Cat (RCAT)

Red Cat Holdings, Inc. engages in the provision of various products, services, and solutions to the drone industry. The company operates through two segments: Enterprise and Consumer. It built infrastructure to manages drone fleets and fly, and provide services remotely, navigate confined industrial interior spaces and dangerous military environment.

Read Our Latest Research Report on RCAT

Peraso (PRSO)

Peraso Inc., a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules.

Read Our Latest Research Report on PRSO

Direxion Daily PLTR Bear 1X Shares (PLTD)

Read Our Latest Research Report on PLTD

Vale (VALE)

Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally. The company operates through Iron Solutions and Energy Transition Materials segments. The Iron Solutions segment produces and extracts iron ore and pellets, manganese, and other ferrous products; and provides related logistic services.

Read Our Latest Research Report on VALE

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Day One Biopharmaceuticals Right Now?

Before you consider Day One Biopharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Day One Biopharmaceuticals wasn't on the list.

While Day One Biopharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines